Is muscarinic receptor agonist effective and tolerant for schizophrenia?
Abstract Background Several randomized clinical trials (RCTs) have recently examined the efficacy and tolerability of muscarinic receptor agonists in schizophrenia. However, whether therapeutics targeting muscarinic receptors improve symptom management and reduce side effects remains systemically un...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-04-01
|
| סדרה: | BMC Psychiatry |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12888-025-06662-1 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|